Author

Felicity Newell

QIMR Berghofer Medical Research InstituteORCID 0000-0003-0469-2705Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Aimee L. DavidsoniD· 1 shared Alvis BrāzmaiD· 1 shared Andrea Garrett· 1 shared Ann‐Marie PatchiD· 1 shared Asmerom Tesfamariam SengaliD· 1 shared Christine ParkinsoniD· 1 shared Claire M. DaviesiD· 1 shared David J. AdamsiD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aimee L. DavidsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsGenome MedicinePeer-reviewedJan 10, 2022

Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib

Vanessa Bonazzi, Olga Kondrashova, Deborah S. Smith…·Pamela M. Pollock

The paper develops endometrial cancer PDX models that capture tumor heterogeneity and predict response to talazoparib.

35 citationstop 2%

humanwhole-exome sequencing

𝕏 PostBluesky

BioinformaticsNature CommunicationsPeer-reviewedFeb 18, 2021

Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study

Manik Garg, Dominique‐Laurent Couturier, Jérémie Nsengimana…·Roy Rabbie

This paper develops a gene expression signature, Cam_121, to predict long-term outcomes in primary melanoma patients, showing improved accuracy compared to clinical and existing prognostic models.

70 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky